Connect with us

Published

on

Share on Pinterest In addition to the high price tag associated with drugs like Ozempic, Wegovy, and Mounjaro, several other costs you may not have anticipated can accumulate while youre taking weight loss medications. Phynart Studio/Getty ImagesSemaglutides like Wegovy and Ozempic reduce appetite and aid in weight loss and diabetes management. Walmart CEO John Furners comments about customers buying fewer units of food sent snack shares tumbling.Furner recently walked back comments, saying customers are purchasing more overall.Experts say people taking semaglutides may spend money on medications to manage side effects, new clothing that fits, and fitness equipment. However, doctors say that these potentially unexpected expenses are a drop in the bucket compared to the costs of the medications and access issues patients face.

Medications like semaglutide (sold under the brand names Ozempic and Wegovy), have skyrocketed in popularity due to their ability to help people lose weight.

In fact, research from 2021 suggested that a 2.4 mg dose of semaglutide (Wegovys dosing) could lower body weight when combined with lifestyle changes.

Anti-obesity medications like semaglutide, or Wegovy, fight the bodys physiological anti-starvation mechanisms by targeting the energy regulatory center of the brain, the hypothalamus, and addressing obesity-driven dysregulation in signaling pathways and hormone production, Dr. Katherine H. Saunders, DABOM, an obesity expert, co-founder of Intellihealth and clinical assistant professor of Medicine at Weill Cornell Medicine. Individuals who take semaglutide generally think about food differently, feel less hungry, feel full faster, and stay full for longer.

And thats how Walmart recently entered the discussion.

In early October, CEO John Furner told Bloomberg that shoppers taking semaglutide are purchasing less units, slightly less calories.

Business Insider noted that shares of Walmart snacks fell amid the news. Furner reportedly walked back statements in discussions with Morgan Stanley analysts, saying people taking the drug are spending more overall on items like medications to relieve side effects and lifestyle and fitness products.

Prescription drugs that aid with weight loss like Ozempic, Wegovy, and Mounjaro already come with a high price tag (around $1,000 a month without insurance), but people may not realize the cost of taking these medications likely wont end with the price of the drug alone.

For most patients, the benefits of the medication will likely outweigh most of these concerns, but its vital that patients understand the costs that could accumulate during treatment, says Dr. Christopher McGowan, a gastroenterologist, obesity medicine specialist, and the founder of True You Weight Loss. Are customers on weight-loss drugs spending less on food?

Early anecdotal evidence indicates that food companies are concerned or noticing shoppers taking drugs like Wegovy and Ozempic may be spending less on food.

Steve Cahillane, the CEO of Kellanova (Cheez-It, Pringles, and Rice Krispies Treats), said in an interview with Bloomberg that the business is assessing changes weight-loss medications may have on consumer behavior. In an interview with the Wall Street Journal, Smuckers CEO Mark Smucker made similar comments.

In the spring, the New York Post reported restaurants are changing menus and trimming portion sizes to adapt to customer eating habits amid a rise in semaglutide use, and that drumbeat has only grown louder.

Semaglutide changes appetites. Is it feasible that customers are spending or will spend less on food?

Its plausible.

It adds up that patients would consume less foods and, in that regard, buying less perishable items fits that story, says Dr. Konstantinos Spaniolas, the chief of the Division of Bariatric, Foregut, and Advanced GI Surgery at Stony Brook Medicine and the director of the Stony Brook Bariatric and Metabolic Weight Loss Center.

However, its also nuanced and too early to tell.

Individuals on semaglutide might spend less money on food because they eat less, but there are so many factors involved maybe theyre going out to eat more or eating higher quality or more expensive foods, Saunders says. Are there really hidden costs of Ozempic and Wegovy?

This answer also requires nuance.

First, experts say its important to discuss the benefits of weight-loss drugs.

In addition to weight loss, a 2023-published randomized control trial of 529 participants with obesity and heart failure suggested that those who took a 2.4 mg dose of semaglutide once weekly for 52 weeks had substantial improvements in symptoms and ability to function physically than the placebo group.

Novo Nordisk, which manufactures Ozempic, stopped a study on kidney failure in people with diabetes early because an independent data monitoring board recommended the evidence was strong enough to show it would succeed in helping this population.

However, the side effects and results from the drug may prompt consumers to purchase other items. The cost of managing side effects

Spaniolas says GI discomfort, including bloating and nausea, is a common side effect of patients on semaglutide. Another expert agrees and says additional medications arent the first-line treatment for managing these side effects.

For the vast majority of people, its manageable by lifestyle change, Dr. Angela Fitch, FACP, FOMA, the president of the Obesity Medicine Association and chief medical officer of knownwell, a weight-inclusive healthcare company. If you drink too much alcohol or eat too much for dinner, youll feel worse.

Fitch says fried foods like chicken and French fries can also make patients feel nauseous because they sit in the stomach longer.

For patients needing additional assistance managing side effects, medications may be necessary.

McGowan says he prescribes anti-nausea medications like ondansetron (brand-name for generic Zofran), which can retail for around $141 for a bottle of 20 pills.

Some patients may have severe gastrointestinal symptoms that necessitate emergency room visits, clinic appointments, and the need for IV hydration, McGowan says. Missed work due to side effects may result in financial impact.

ER visits can cost more than $1,000, according to American Family Care.

Fitch says that having an attentive care team that can adjust dosing and give insights on side effects and how to manage them can help prevent these costly ER visits. The cost of lifestyle products associated with weight loss drugs

Research indicates that semaglutide and similar medications are effective in helping patients living with overweight or obesity lose and maintain weight when combined with lifestyle changes.

Providers say these changes include physical activity. This need can come at a cost, too.

They also spend money on fitness equipment and gym memberships because cardio and strength training are critical strategies to preserve muscle mass and maintain weight loss long-term, Saunders says.

Costs of gym memberships vary based on the gym a person joins and the state, but Statista data from 2021 indicates monthly fees can range from $38 in Wyoming to more than $75 in New York.

Fitch says consumers may also purchase equipment for their homes.

The more you are losing weight, the better you feel, and you may buy a treadmill, Peloton, or hand weights, Fitch says. I can see a potential for an increase in those things.

Peloton bikes start at around $1,500, plus a membership fee that starts at $12.99 for the app. Prices on hand weights vary but can cost as low as $7 for a set of one, while larger sets can carry three-figure price tags.

Ultimately, Fitch says these costs are typically perceived as investments in health.

I think the data will be positive on quality and length of life, enjoyment of life, and being active, Fitch says.

For instance, the drugs and increased activity might also reduce costs associated with medical care for heart disease.

A new wardrobe may also be necessary to accommodate weight loss.

Our patients definitely sped money on new clothing as they lose weight, Saunders says. One inch on the waist is roughly equivalent to 8 pounds of lost weight.

But Saunders says patients are excited about the weight loss, and Fitch points out, You buy new clothes every time you gain weight.Accessing weight loss medication may cost you a lot of time too

Experts share that the most significant hidden cost of semaglutide (besides the drugs themselves) is time.

Given the supply shortages, patients frequently tell me they are forced to spend many hours contacting or driving to multiple pharmacies to acquire their medications or risk missing doses, which could jeopardize their progress, McGowan says.

Fitch has also noticed this issue.

To stay on Wegovy is like a full-time job. Fitch says, recalling a recent discussion with a patient whose mother stays home and found the drug for them. Thats not going to happen when you have three jobs and can barely make ends meet. Youre not going to call around to five pharmacies to access Wegovy.

And thats a problem.

These medications are not intended or designed for someone to take the medication to lose 20 or 30 pounds, and then once they lose it, you can stop your medications and move on with life, Spaniolas said. Once you stop them, the weight usually comes back.

Indeed, a trial of almost 2,000 people published in 2022 suggested that people who ceased use of 2.4 mg semaglutide doses had regained two-thirds of the lost weight within one year. The most significant cost: The semaglutide prescription itself

It doesnt help that insurance will not always cover these drugs for weight loss, and more companies are dropping coverage.

A 2003 law bars Medicare from covering weight loss drugs.

Without insurance coverage, the cost of the GLP-1 medications is prohibitive, McGowan says. The average retail price of Wegovy is $1,349. Its essential to keep in mind that that number is monthly every month.

That means a person will spend more than $16,000 annually out-of-pocket on Wegovy, a drug meant for long-term use.

The GLP-1 medications are chronic treatments intended to be used long-term, McGowan says. Therefore, that is not a cost-effective proposition. Tips to help manage the cost of weight loss drugs and related expenses

Not everyone can afford weight-loss drugs, and Saunders says that increased insurance coverage, lower prices, and shoring-up supply chain issues are among the greatest systemic issues that need to change.

Fitch says weight bias also plays a role in the approach to these drugs, including insurance coverage.

Were not asked to prove cost-effectiveness with any other disease, Fitch says. Its not cost-effective to treat cancerbut we dont let people die. But theres so much with obesity. Its a journey. Its a chronic disease, too.

In the interim, Saunders recommends patients:Speak with providers about ways to treat side effects other than medications, including eating habits.Invest in a fitness routine you can sustain, including aerobic and strength training that works for you.Find a care team that supports you. Even if you got lucky and lost weight relatively easily, you will inevitably hit bumps in the road during your weight journey, and youll need your care team to help you get back on track each time, Saunders says.

Spaniolas suggests giving yourself a whole serving of grace about expenses and access.

Youre doing the best you can with what is available to you, Spaniolas says. Takeaway

Food industry and retail executives and weight loss experts agree that its possible that weight loss drugs like Wegovy, Ozempic, and Mounjaro may influence purchasing behaviors.

Customers may spend less on food because of appetite reductions and more on fitness products, new clothes, and managing side effects of the drugs.

However, few people will lament this investment, McGowan says.

Experts say the most significant costs of these medications stem from supply-chain issues that have triggered drug shortages, making accessing them a full-time job. And thats if you can afford them.

Insurances do not always cover these drugs for weight loss, which cost more than $1,000 per month out of pocket, and more are announcing they will drop them.

Experts share this needs to change so people can access these drugs, which can better health outcomes beyond weight loss, including a reduction in heart disease symptoms.

Continue Reading

Technology

Amazon CEO Jassy says AI will lead to ‘fewer people doing some of the jobs’ that get automated

Published

on

By

Amazon CEO Jassy says AI will lead to 'fewer people doing some of the jobs' that get automated

AI will change the workforce, says Amazon CEO Andy Jassy

Amazon CEO Andy Jassy said the rapid rollout of generative artificial intelligence means the company will one day require fewer employees to do some of the work that computers can handle.

“Like with every technical transformation, there will be fewer people doing some of the jobs that the technology actually starts to automate,” Jassy told CNBC’s Jim Cramer in an interview on Monday. “But there’s going to be other jobs.”

Even as AI eliminates the need for some roles, Amazon will continue to hire more employees in AI, robotics and elsewhere, Jassy said.

Earlier this month, Jassy admitted that he expects the company’s workforce to decline in the next few years as Amazon embraces generative AI and AI-powered software agents. He told staffers in a memo that it will be “hard to know exactly where this nets out over time” but that the corporate workforce will shrink as Amazon wrings more efficiencies out of the technology.

It’s a message that’s making its way across the tech sector. Salesforce CEO Marc Benioff last week claimed AI is doing 30% to 50% of the work at his software vendor. Other companies such as Shopify and Microsoft have urged employees to adopt the technology in their daily work. The CEO of Klarna said in May that the online lender has managed to shrink its headcount by about 40%, in part due to investments in AI and natural attrition in its workforce.

Jassy said on Monday that AI will free employees from “rote work” and “make all our jobs more interesting,” while enabling staffers to invent better services more quickly than before.

Amazon and other tech companies have also been shrinking their workforces through rolling layoffs over the past several years. Amazon has cut more than 27,000 jobs since the start of 2022, and it’s announced smaller, more targeted layoffs in its retail and devices units in recent months.

Amazon shares are flat so far this year, underperforming the Nasdaq, which has gained 5.5%. The stock is about 10% below its record reached in February, while fellow megacaps Meta, Microsoft and Nvidia are all trading at or very near record highs.

WATCH: Jassy says robots that will eventually do delivery and transportation

Over time we will have robots that will do delivery and transportation, says Amazon CEO Andy Jassy

Continue Reading

Politics

PM faces threat of major rebellion during key vote today

Published

on

By

PM faces threat of major rebellion during key vote today

Sir Keir Starmer continues to face the threat of a major rebellion during a key vote on welfare reforms later – despite making last-minute concessions to disgruntled Labour MPs.

Work and Pensions Secretary Liz Kendall has confirmed that all existing claimants of the personal independence payment (PIP), the main disability benefit, will be protected from changes to eligibility.

The combined value of the standard Universal Credit allowance and the health top-up will rise “at least in line with inflation” every year of this parliament.

And an additional £300m for employment support for sick and disabled people in 2026 has been announced, which will rise every year after.

Please use Chrome browser for a more accessible video player

Welfare cuts ‘needed to be made’

Ms Kendall has also promised that a consultation into PIP – “co-produced” with disabled people – will be published next autumn.

She said the U-turn on welfare cuts will cost taxpayers about £2.5bn by 2030 – less than half the £4.8bn the government had expected to save with its initial proposals.

Modelling by Ms Kendall’s own department, released yesterday, suggested the proposals would push 150,000 more people into poverty by 2030, down from the 250,000 estimated under the original plan.

More from Politics

But after announcing the U-turns, Labour MPs were still publicly saying they could not back the plans as they do not go far enough to allay their concerns.

Disabilities minister Stephen Timms would not say he was “confident” the proposals would pass the Commons when asked on Sky News’ Politics Hub with Sophy Ridge.

“We’ve got a very strong package, I certainly hope it passes,” he replied.

Read more: What are the concessions to the welfare reform bill?

Please use Chrome browser for a more accessible video player

‘Disabled people thrown under the bus’

A total of 86 charities united yesterday to call on MPs to reject the reforms, saying they will harm disabled people and calling it “a political choice”.

The likes of Oxfam, Child Action Poverty Group, Mind and Shelter said the bill has been brought to a vote without consulting disabled people and without any assessment “of its impact on health and employment outcomes”.

When asked to name “a single” disability organisation in favour of the reforms, Ms Kendall declined to do so.

Several Labour MPs indicated they would still vote against the changes, leaving the government in the dark over how big a rebellion it still may face.

Ms Kendall tried to allay their fears, telling MPs: “I believe we have a fair package, a package that protects existing claimants because they’ve come to rely on that support.”

Richard Burgon presented a petition to parliament yesterday evening against the cuts, signed by more than 77,000 people.

Several Labour MPs questioned why the vote was going ahead before the review into PIP is published – including Rachael Maskell, who said she could not “countenance sick and disabled people being denied support” and added: “It is a matter of conscience.”

Connor Naismith said the concessions “undoubtedly improve efforts to secure welfare reform which is fair”, but added: “Unfortunately, I do not believe these concessions yet go far enough.”

Nadia Whittome
Image:
Labour rebel Nadia Whittome said the government was ‘ignoring’ disabled people

Nadia Whittome accused the government of “ignoring” disabled people and urged ministers to go “back to the drawing board”.

Ian Byrne told the Commons he will vote against the “cruel cuts” to disability benefits because the “so-called concessions go nowhere near far enough”.

The vote will take place this evening, with coverage on Sky News’ Politics Hub live blog and on TV.

Continue Reading

World

Benjamin Netanyahu to meet Donald Trump next week amid calls for Gaza ceasefire

Published

on

By

Benjamin Netanyahu to meet Donald Trump next week amid calls for Gaza ceasefire

Israeli Prime Minister Benjamin Netanyahu will be meeting Donald Trump next Monday, according to US officials.

The visit on 7 July comes after Mr Trump suggested it was possible a ceasefire in Gaza could be reached within a week.

On Sunday, he wrote on social media: “MAKE THE DEAL IN GAZA. GET THE HOSTAGES BACK!!!”

At least 60 people killed across Gaza on Monday, in what turned out to be some of the heaviest attacks in weeks.

Israeli Prime Minister Benjamin Netanyahu, left, with US President Donald Trump. Pic: Reuters
Image:
Benjamin Netanyahu, left, with Donald Trump during a previous meeting. Pic: Reuters

According to the Hamas-run health ministry, 56,500 people have been killed in the 20-month war.

The visit by Mr Netanyahu to Washington has not been formally announced and the officials who said it would be going ahead spoke on condition of anonymity.

An Israeli official in Washington also confirmed the meeting next Monday.

More on Benjamin Netanyahu

White House Press Secretary Karoline Leavitt said the administration was in constant communication with the Israeli government.

She said Mr Trump viewed ending the war in Gaza and returning remaining hostages held by Hamas as a top priority.

Read more from Sky News:
Queen Elizabeth II’s favourite form of transport to be scrapped
How does sunscreen work?

Follow The World
Follow The World

Listen to The World with Richard Engel and Yalda Hakim every Wednesday

Tap to follow

The war in Gaza broke out in retaliation for Hamas’ 7 October 2023 attacks on southern Israel that killed 1,200 people and saw a further 250 taken hostage.

An eight-week ceasefire was reached in the final days of Joe Biden’s US presidency, but Israel resumed the war in March after trying to get Hamas to accept new terms on next steps.

Talks between Israel and Hamas have stalled over whether the war should end as part of any ceasefire.

Continue Reading

Trending